Jianming Ying

Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC

Shugeng Gao, Ning Li, Shun‐Yu Gao et al. · Journal of Thoracic Oncology · 2020 · 415 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation

Jianming Ying, H Li, T J Seng et al. · Oncogene · 2005 · 283 citations

Medicine, Cancer Biology, Oncology +15

Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody–Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma

Xinan Sheng, Xieqiao Yan, Lin Wang et al. · Clinical Cancer Research · 2020 · 281 citations · Full text

Medicine, Oncology, Pharmacology +17

Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?

Lei Yang, Di Dong, Mengjie Fang et al. · European Radiology · 2018 · 250 citations

Medicine, Oncology, Radiology +16

DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function

Bilian Jin, Qian Tao, Jinrong Peng et al. · Human Molecular Genetics · 2007 · 236 citations · Full text

Life Sciences, Genetics, Molecular Biology +17